Skip to main content
SpringerLink
Log in

Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This study was designed to explain the action of sodium cromoglycate (CRO) on the brain serotonergic system in control, morphine tolerant (by SC implantation of a 75 mg morphine pellet), and also in morphine dependent mice just before naloxone-precipitated withdrawal. After SC injections of CRO in control mice, morphine tolerant mice (day 4 of addiction), and 1 h before abstinence (withdrawal was induced by SC injection of 1 mg/kg naloxone on day 4 of addiction), animals were decapitated and various brain areas were rapidly removed. 5HT (Serotonin) and 5HIAA (5-hydroxyindole-3-acetic acid) were measured by high performance liquid chromatography coupled with electrochemical detection (HPLC-ECD). The ratio 5HIAA/5HT provided one index by which the turnover of the indoleamine was measured. CRO increased the turnover of 5HT in most of the brain areas studied in both control and morphine dependent mice. Furthermore, previous administration of CRO prior to naloxone challenge induced a significant increase in the 5HIAA/5HT ratio in the hypothalamus and striatum. These results are discussed as the reason for the preventive effect of CRO on jumping behaviour in morphine abstinent mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Botting R, Morinan A (1982) Involvement of 5-hydroxytryptamine in the analgesic action of pethidine and morphine in mice. Br J Pharmacol 75:579–585

    PubMed  Google Scholar 

  • Carroll BJ, Sharp PT (1972) Monoamine mediation of morphine-induced activation of mice. Br J Pharmacol 46:124–139

    PubMed  Google Scholar 

  • Cervo L, Rochat C, Romandini S, Samanin R (1981) Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats. Psychopharmacology 74:271–274

    Article  PubMed  Google Scholar 

  • Cervo L, Romandini S, Samanin R (1983) Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine dependent rats. Br J Pharmacol 79:993–996

    PubMed  Google Scholar 

  • Colado MI, Alfaro MJ, Lopez F, Del Val V, Martín MI (1991) The effect of dihydropyridine calcium channel agents on 5HT metabolism in the CNS of the rat. J Pharm Pharmacol 43:662–664

    PubMed  Google Scholar 

  • Djaldetti M, Van der Lijn E, Notti I (1979) Ultrastructural observations on mast cell degranulation and its prevention. Nouv Rev Fr Hematol 21:185–196

    PubMed  Google Scholar 

  • Gibson RD, Tingstad TE (1970) Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. J Pharm Sci 59:426–427

    PubMed  Google Scholar 

  • Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain — I. J Neurochem 13:655–669

    PubMed  Google Scholar 

  • Grzanna R, Shultz LD (1982) The contribution of mast cells to the histamine content of the central nervous system: a regional analysis. Life Sci 30:1959–1964

    Article  PubMed  Google Scholar 

  • Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165–229

    PubMed  Google Scholar 

  • Johnson HG, White GJ (1979) Development of new antiallergic drugs (cromolyn sodium, lodoxamide tromethamine). What is the role of cholinergic stimulation in the biphasic dose response? Monogr Allerg 14P:299–306

    Google Scholar 

  • Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neuro Sci 15:186–191

    Article  Google Scholar 

  • Langwinski R, Fidecka S (1981) Central actions of narcotic analgesics VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats. Pol J Pharmacol Pharm 33:193–202

    PubMed  Google Scholar 

  • Lavin N, Rachelefsky GS, Kaplan SA (1976) An activation of disodium cromoglycate: inhibition of cyclic 3′-5′-AMP phosphodiesterase. J Allerg Clin Immunol 57:80–88

    Article  Google Scholar 

  • Leza JC, Lizasoain I, Martín MI, Lorenzo P (1988) Effects of nifedipine, verapamil and diltiazem on naloxone-induced abstinence in morphine-dependent mice. Rev Farmacol Clin Exp 5:383–387

    Google Scholar 

  • Leza JC, Lizasoain I, Lorenzo P (1990a) Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice. Psychopharmacology 102:106–111

    PubMed  Google Scholar 

  • Leza JC, Lizasoain I, Lorenzo P (1990b) H1- and H2-histamine receptors blockers and opiate analgesia in mice. Methods Find Exp Clin Pharmacol 12:671–678

    PubMed  Google Scholar 

  • Leza JC, Lizasoain I, Lorenzo P (1991) Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol 22:293–296

    PubMed  Google Scholar 

  • Leza JC, Lizasoain I, San-Martin-Clark O, Lorenzo P (1992) Role of sodium cromoglycate on analgesia, locomotor activity and opiate withdrawal in mice. Psychopharmacology 107:595–600

    Article  PubMed  Google Scholar 

  • Maeyama K, Watanabe T, Yamatodani A, Taguchi Y, Kambe H, Wada H (1983) Effect of alpha-fluoromethyl-histidine on the histamine content of the brain of W/WV mice devoid of mast cells: turnover of brain histamine. J Neurochem 41:128–134

    PubMed  Google Scholar 

  • Malec D, Langwinski R (1983) The effects of antihistaminics on cataleptogenic action of analgesics and haloperidol. Pol J Pharmacol Pharm 35:293–300

    PubMed  Google Scholar 

  • Maruyama J, Takemori AE (1973) The role of dopamine and noreprinephrine in the naloxone-induced abstinence of morphine-dependent mice. J Pharmacol Exp Ther 185:602–608

    PubMed  Google Scholar 

  • Moore JB (1977) Regulation of intracellular cyclic GMP and cyclic AMP levels in mouse lung fragments by disodium cromoglycate, beta adrenergic agonists, cholinergic activators and histamine. Res Commun Chem Pathol Pharmacol 17:639–647

    PubMed  Google Scholar 

  • Pearce FL, Al-Laith M, Bosman L, Brostoff J, Cunniffe TM, Flint KC, Hudspith BN, Jaffar ZH, Johnson NM, Kassessinoff TA, Lau HYA, Lee PY, Leung KBP, Liu WL, Tainnsh KR (1989) Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 37:37–43

    PubMed  Google Scholar 

  • Richards IM, Dixon M, Jackson DM, Vendy K (1986) Alternative modes of action of sodium cromoglycate. Agents Actions 18:294–300

    Article  PubMed  Google Scholar 

  • Romandini S, Cervo L, Samanin R (1984) Evidence that drugs increasing 5-hydroxytryptamine transmission block jumping but not wet dog shakes in morphine-abstinent rats: a comparison with clonidine. J Pharm Pharmacol 36:68–70

    PubMed  Google Scholar 

  • Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71:1–51

    PubMed  Google Scholar 

  • Showalter CV (1980) T's and blues. JAMA 244:1224–1225

    Article  PubMed  Google Scholar 

  • Snelgar RS, Vogt M (1981) Mapping in the rat CNS of morphine-induced changes in turnover of 5-hydroxytryptamine. J Physiol (Lond) 314P:395–410

    Google Scholar 

  • Strang J (1985) Abuse of buprenorphine. Lancet II:275

    Google Scholar 

  • Taber RI, Latranyi MB (1981) Antagonism of the analgesic effect of opioid and non-opioid agents byp-chlorophenylalanine (PCPA). Eur J Pharmacol 75:215–222

    Article  PubMed  Google Scholar 

  • Tallarida RJ, Murray RB (1981) Manual of pharmacologic calculations with computer programs. Springer, Berlin Heidelberg New York, pp, 54–55

    Google Scholar 

  • Wells E, Mann J (1983) Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds. Implications for the mode of action of sodium cromoglycate. Biochem Pharmacol 32:837–842

    Article  PubMed  Google Scholar 

  • Yamasaki Y, Shimamura O, Kizu A, Nakagawa M, Ijichi H (1982) IgE mediated14C serotonin release from rat mast cells modulated by morphine and endorphins. Life Sci 31:471–478

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Farmacología, Facultad de Medicina, Universidad Complutense, E-28040, Madrid, Spain

    Olivia San-Martin-Clark, Juan-Carlos Leza, Ignacio Lizasoain & Pedro Lorenzo

Authors
  1. Olivia San-Martin-Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan-Carlos Leza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ignacio Lizasoain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

San-Martin-Clark, O., Leza, JC., Lizasoain, I. et al. Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice. Psychopharmacology 111, 233–238 (1993). https://doi.org/10.1007/BF02245529

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245529

Key words

Search

Navigation